Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and ¹⁸fluorodeoxyglucose (FDG) positron emission tomography (PET)

References

• Basavaraj KH, Navya MA, Rashmi R. Relevance of psychiatry in dermatology: Present concepts. Indian J Psychiatry. 2010;52:270–275.
   PubMedGoogle Scholar
• Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 203-2004. J Am Acad Dermatol. 2009;60:218–224.
   PubMed Web of Science ®Google Scholar
• Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984–991.
   PubMed Web of Science ®Google Scholar
• Kurd SK, Toxel AB, Crits-Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–895.
   PubMed Web of Science ®Google Scholar
• Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010;23:174–180.
   PubMed Web of Science ®Google Scholar
• Adamizik K, Mcaleer MA, Kirby B. Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol. 2013;38:819–822.
   PubMed Web of Science ®Google Scholar
• Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–1980.
   PubMed Web of Science ®Google Scholar
• Breuer K, Goldner FM, Jager B, et al. Chronic stress experience and burnout syndrome have appreciable influence on health-related quality-of-life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2015;29:1898–1904.
   PubMed Web of Science ®Google Scholar
• Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical disease. J Am Acad Dermatol. 1999;41:401–407.
   PubMed Web of Science ®Google Scholar
• Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med. 1985;20:425–429.
   PubMed Web of Science ®Google Scholar
• Dowlatshahi EA, Wakkee M, Arends LR, et al. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134:1542–1551.
   PubMed Web of Science ®Google Scholar
• Lee B. Handbook of clinical rating scales and assessment in psychiatry and mental health, current clinical psychiatry. Boston, Humana Press; 2009.
   Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial. Lancet. 2006;367:29–35.
   PubMed Web of Science ®Google Scholar
• Dommasch ED, Li T, Okereke OI, et al. Risk of depression in women with psoriasis: a cohort study. Br J Dermatol. 2015;173:975–980.
   PubMed Web of Science ®Google Scholar
• Wojtyna E, Lakuka P, Marcinkiewicz K, et al. Gender, body image and social support: biopsychosocial determinants of depression among patients with psoriasis. Acta Derm Venereol. 2017;96:91–97.
   Google Scholar
• Begmann K, Schulz W, Wohlleben J, et al. Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors. Hautarzt. 2014;65:1056–1061.
   PubMed Web of Science ®Google Scholar
• Fleming P, Roubille C, Richer V, et al. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2015;29:1898–1904.
   PubMed Web of Science ®Google Scholar
• Leonardi CL, Kimbell AB, Papp KA, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008;371:1665–1674.
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Strober BE, van de Kerkhof P, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med. 2010;362:118–128.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Papp KA, Wasfi Y, et al. Long-term efficacy of ustekinumab in patients with moderate to severe psoriasis treated for up to 5 years in the PHONEX 1 study. J Eur Acad Dermatol Venereol. 2013;27:1535–1545.
   PubMed Web of Science ®Google Scholar
• Langley RG, Feldman SR, Han C, et al. Ustekinumab significantly impoves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010;63:457–465.
   PubMed Web of Science ®Google Scholar
• Nam HY, Song SH, Kim SJ, et al. Effect of dialysis on cerebral blood flow in depressive end-stage renal disease patients. Ann Nucl Med. 2011;25:165–171.
   PubMed Web of Science ®Google Scholar
• Saito T, Hama M, Chiba Y, et al. Brain FDG-PET reflecting clinical course of depression induced by systemic lupus erythematosus: Two case reports. J Neurol Sci. 2015;358:464–466.
   PubMed Web of Science ®Google Scholar
• Su L, Cai Y, Xu Y, et al. Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry. 2014;14:321.
   PubMed Web of Science ®Google Scholar
• Aberra TM, Joshi AA, Lerman JB, et al. Self-reported depression in psoriasis is associated with subclinical vascular diseases. Atherosclerosis. 2016;251:219–225.
   PubMed Web of Science ®Google Scholar
• Videlbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorders: A clinical review. Acta Psychiatr Scand. 2000;101:11–20.
   PubMed Web of Science ®Google Scholar
• Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci. 1999;877:614–637.
   PubMed Web of Science ®Google Scholar
• Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res. 2000;126:413–431.
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, Weidmann A, et al. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol. 2004;151:1227–1233.
   PubMed Web of Science ®Google Scholar
• Renzi C, Picardi A, Abeni D, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol. 2002;138:337–342.
   PubMed Web of Science ®Google Scholar
• Kulkarni AS, Balkrishnan R, Camacho FT, et al. Mediation and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol. 2004;3:661–666.
   PubMedGoogle Scholar